Scientists at Bradford University have created a process of co-crystallisation, which is a faster alternative to traditional methods of creating targeted soluble drug compounds with greater efficiency.
The research was carried out at the university’s Centre for Pharmaceutical Engineering Science, which offers expertise in the areas of pharmaceutical materials, drug delivery systems, novel process development, reactive extrusion, material characterisation and process analytical technology.
The technique employed by the pioneering team lends itself to global, industrial-scale manufacturing due to its scalable, continuous and solvent-free nature.
Researchers are now looking to gain a greater understanding of the science behind the process as part of a three-year project funded by Engineering and Physical Sciences Research Council.
Anant Paradkar, professor of Bradford University’s Centre for Pharmaceutical Engineering Science, said: “This is a really exciting project. Not only will we understand how the process works - which will enable the creation of new co-crystals - we’ll also be assessing how these might be delivered to patients.
PCMG Annual Conference, 05-07 June 2013, Budapest
Outsourcing in Clinical Trials for Nordic Companies, 11-12 September, Copenhagen
BioPartnering Future Europe, 13-16 October, Stockholm